I. MCIT Pathway CMS proposes to establish the MCIT pathway to provide immediate national Medicare coverage for devices designated as part of the Food and Drug Administration's (FDA) Breakthrough ...

This TCET program requires collaboration between two agencies within the Department of Health and Human Services that operate under different statutory authorities and according to different standards ...

While the Medicare Coverage of Innovative Technologies (MCIT) program has been formally abandoned, the U.S. CMS has resurrected those policy underpinnings in the form of the Transitional Coverage for ...

On August 7, 2024, the Centers for Medicare & Medicaid Services (“CMS” or the “Agency”) issued a final procedural notice (“Notice”) outlining a new Medicare coverage pathway, aimed at achieving ...

If the MCIT coverage expires and there is a void of LCDs or an NCD for an extended period of time, there will almost definitely be a period of coverage status and access confusion, as coverage will ...